DNLI
NASDAQStockDenali Therapeutics Inc.
$20.74-0.91 (-4.21%)
52-Week Range
$11.47
$22.74
Key Stats
Market Cap
3.2B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.08
Volume
960.9K
Avg Volume
1.6M
Performance
1M
+5.13%
3M
+19.38%
6M
+57.29%
YTD
+27.23%
1Y
+39.02%
3Y
-12.18%
5Y
-66.62%
Price Chart
ETF Exposure
DNLI is held by 88 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SMMD | iShares Russell 2500 ETF | 0.02% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.01% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.01% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.01% |
| DFUS | Dimensional - US Equity Market ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VT | Vanguard Total World Stock ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About DNLI ETF Exposure
Denali Therapeutics Inc. (DNLI) is held by 88 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.2B, DNLI is a widely held institutional stock. The stock currently trades at $20.74. Investors can gain exposure to DNLI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DNLI, sorted by portfolio weight.